English-Spanish translation for "breast cancer"

Every 20 minutes, a woman dies of breast cancer in Europe.

The patenting of the breast cancer gene BRAC1 has attracted controversy.

Randomised trials of single agent chemotherapy compared to combination therapy in metastatic breast cancer.

This year's theme, for instance, is the prevention, early detection and screening of breast and cervical cancer.

Screening with mammography uses X-ray to try to find breast cancer before a lump can be felt.

See also: The Cochrane Library Special Collection on "Breast Cancer Detection" and a related post in the Cochrane Collaboration Official Blog.

The BBC News and The Guardian report on the planned review of the UK breast cancer screening policy citing the relevant Cochrane systematic review.

Women with breast cancer who have multiple positive lymph nodes when first diagnosed are at high risk of recurrence.

Our request to governments to create, by 2008, the conditions required for a 25 % reduction in the breast-cancer mortality rate in the EU is not unrealistic.

The review estimated that screening leads to a reduction in breast cancer mortality of 15% and to 30% overdiagnosis and overtreatment.

There is also, in my view, a very grave concern which has been expressed to me by the National Hereditary Breast Cancer Helpline, which is based in my constituency.

Adjuvant endocrine therapy is an integral component of care for ER+ breast cancer, exerting its effect by reducing the availability of oestrogen to micrometastatic tumour cells.

This review found that for women with advanced breast cancer, taking antitumour antibiotics did not result in better survival than women who took other types of chemotherapy drugs.

Furthermore, the virtual monopoly on test methods pushes costs so high that early detection of breast cancer is no longer available to many women.

Hormonal treatments are used to control such symptoms in postmenopausal women but for women with a history of breast cancer these are not recommended as they can induce cancer growth.

Young men are the most likely to develop breast cancer because of the wide use of female hormones and metabolisers, which spark off gynaecomastia which often goes untreated.

We have no solid proof that they are yet affecting humans but there are many indicators such as the decline in sperm counts, and the rise in testicular and breast cancer.

Details of the search strategy applied to create the register, and the procedure used to code references, are described in the Cochrane Breast Cancer Group module on The Cochrane Library.

The review found that screening for breast cancer likely reduces breast cancer mortality, but the magnitude of the effect is uncertain.

Other gender diseases that have been mentioned more often in this debate, such as breast cancer and osteoporosis, are at a rather more advanced stage in terms of prevention, diagnosis and treatment.